Lee McCracken
CEO
Lee is Chief Executive Officer and a member of the Board of Directors of Drawbridge Health.
Prior to joining Drawbridge Health in 2017, Lee served as CEO of Gensignia Life Sciences, CEO of Pathwork Diagnostics, and Corporate Head of Business Development for Prometheus Laboratories (Nestlé Health Science). Earlier in his career, he held executive positions at several biotechnology and pharmaceutical companies including GenStar Therapeutics, CombiChem, and Allergan, and the venture capital firms, 3i Capital and Union Venture.
Lee received his MBA from the Anderson School of Management at UCLA, his MS in Computer Science from the University of Dayton, and his BS in Commerce from Santa Clara University. He currently serves as a director of several public and private companies.
